19 May 2013
Keywords: fda, approves, merck, co, januvia, food, drug
Article | 23 October 2006
The US Food and Drug Administration has approved Januvia (sitagliptin), Merck& Co's once-daily medication for type 2 diabetes. The oral drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2006
17 May 2013
© 2013 thepharmaletter.com